Evidence based approach for the management of mixed hyperlipidaemia

Related Experiment Video

Updated: Aug 10, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

A Gaw1

  • 1Dept. of Pathological Biochemistry, Glasgow Royal Infirmary, Scotland, UK.

Atherosclerosis
|August 7, 1998
PubMed

Insights

Lowering LDL-cholesterol significantly reduces coronary heart disease (CHD) risk. The Helsinki Heart Study also highlights the importance of raising HDL-cholesterol and lowering triglycerides for CHD event reduction.

Area of Science:

  • Cardiology
  • Lipidology
  • Preventive Medicine

Background:

  • Extensive clinical trials confirm that reducing low-density lipoprotein (LDL)-cholesterol levels lowers coronary heart disease (CHD) risk.
  • The Helsinki Heart Study (HHS) provides further insights into the impact of other lipid changes on CHD incidence.

Purpose of the Study:

  • To analyze the relationship between lipid profile changes and CHD event reduction in the Helsinki Heart Study.
  • To compare the effects of different lipid-lowering drug classes on atheroma regression and coronary artery diameter.

Main Methods:

  • Analysis of data from the Helsinki Heart Study, focusing on lipid profiles and CHD events.
  • Comparison of drug classes (statins vs. fibrates) for their effects on LDL-cholesterol, HDL-cholesterol, triglycerides, and coronary artery lumen diameter.

Main Results:

  • CHD event reduction in HHS was associated with LDL-cholesterol lowering, HDL-cholesterol raising, and triglyceride lowering.
  • Statins significantly reduce total and LDL-cholesterol, while fibrates show a greater effect on coronary artery minimum lumen diameter, indicating atheroma regression.

Conclusions:

  • A comprehensive approach to managing CHD risk factors is essential.
  • Lifestyle changes and, if necessary, lipid-regulating drugs should be used to normalize lipid profiles.
  • While LDL-cholesterol reduction is crucial, the role of triglyceride lowering in managing CHD risk should not be underestimated.

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...